FDA cleared the Tutamen Self Adhesive Electrodes from Dongguan Tutamen Metalwork Co., Ltd. on May 1, 2026 under K252439, a traditional 510(k). The device falls under product code GXY, Electrode, Cutaneous, regulated at 21 CFR 882.1320 as a Class 2 device. The review panel was Neurology.

FDA logged the submission as received on Aug 4, 2025. The decision came 270 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Dongguan Tutamen Metalwork Co., Ltd. in the last 12 months of the tracker.